Literature DB >> 16597568

The impact of 9/11 on New York City's substance abuse treatment programs: a study of program administrators.

Blanche Frank1, Tracey Dewart, James Schmeidler, Arlene Demirjian.   

Abstract

Given the far-reaching effects of the terrorist attacks on September 11, 2001, a study was conducted under the supervision of the New York State Office of Alcoholism and Substance Abuse Services to assess the impact on New York City's substance abuse treatment programs. A stratified, random sample of 15 treatment programs was selected to represent the system's major modalities. Administrators representing these programs were interviewed face-to- face using a structured interview schedule. The questions mainly probed the problems experienced on 9/11 and afterwards, patient issues and the lessons learned. The findings show major concerns for the mental health of both staff members and patients, the failure of the telephone communication system, the particular sensitivity of drug-free outpatient clinics, the challenges experienced by methadone programs, and the need to update disaster planning. A host of problems came to the fore now requiring another level of thinking.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16597568     DOI: 10.1300/J069v25n01_03

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  9 in total

1.  Psychiatric comorbidity, red flag behaviors, and associated outcomes among office-based buprenorphine patients following Hurricane Sandy.

Authors:  Arthur R Williams; Babak Tofighi; John Rotrosen; Joshua D Lee; Ellie Grossman
Journal:  J Urban Health       Date:  2014-04       Impact factor: 3.671

2.  Immediate Impact of Hurricane Sandy on People Who Inject Drugs in New York City.

Authors:  Enrique R Pouget; Milagros Sandoval; Georgios K Nikolopoulos; Samuel R Friedman
Journal:  Subst Use Misuse       Date:  2015-03-16       Impact factor: 2.164

3.  Characterizing Self-Reports of Self-Identified Patient Experiences with Methadone Maintenance Treatment on an Online Community during COVID-19.

Authors:  Alicia L Nobles; Derek C Johnson; Eric C Leas; David Goodman-Meza; María Luisa Zúñiga; Douglas Ziedonis; Steffanie A Strathdee; John W Ayers
Journal:  Subst Use Misuse       Date:  2021-09-05       Impact factor: 2.362

4.  Effects of regulation on methadone and buprenorphine provision in the wake of Hurricane Sandy.

Authors:  Bridget McClure; Sonia Mendoza; Laura Duncan; John Rotrosen; Helena Hansen
Journal:  J Urban Health       Date:  2014-10       Impact factor: 3.671

5.  Impacts of COVID-19 on residential treatment programs for substance use disorder.

Authors:  Anna Pagano; Sindhu Hosakote; Kwinoja Kapiteni; Elana R Straus; Jessie Wong; Joseph R Guydish
Journal:  J Subst Abuse Treat       Date:  2020-12-17

6.  Opioid treatment program safety measures during the COVID-19 pandemic: a statewide survey.

Authors:  Sachini Bandara; Hannah Maniates; Eric Hulsey; Jennifer S Smith; Ellen DiDomenico; Elizabeth A Stuart; Brendan Saloner; Noa Krawczyk
Journal:  BMC Health Serv Res       Date:  2022-03-30       Impact factor: 2.655

7.  COVID 19 and the Opioid Epidemic: An Analysis of Clinical Outcomes During COVID 19.

Authors:  Chiemeka Ezie; Ryan Badolato; Mary Rockas; Rayek Nafiz; Brian Sands; Adam Wolkin; Pantea Farahmand
Journal:  Subst Abuse       Date:  2022-04-22

8.  Outcomes among buprenorphine-naloxone primary care patients after Hurricane Sandy.

Authors:  Babak Tofighi; Ellie Grossman; Arthur R Williams; Rana Biary; John Rotrosen; Joshua D Lee
Journal:  Addict Sci Clin Pract       Date:  2014-01-27

Review 9.  Opioid use disorder treatment disruptions during the early COVID-19 pandemic and other emergent disasters: a scoping review addressing dual public health emergencies.

Authors:  Rita Henderson; Ashley McInnes; Leslee Mackey; Myles Bruised Head; Lindsay Crowshoe; Jessica Hann; Jake Hayward; Brian R Holroyd; Eddy Lang; Bonnie Larson; Ashley Jane Leonard; Steven Persaud; Khalil Raghavji; Chris Sarin; Hakique Virani; Iskotoahka William Wadsworth; Stacey Whitman; Patrick McLane
Journal:  BMC Public Health       Date:  2021-07-28       Impact factor: 3.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.